Scienture (NASDAQ:SCNX) Trading Down 6.6% – Time to Sell?

Posted by Defense World Staff on Jul 22nd, 2026

Scienture Holdings, Inc. (NASDAQ:SCNX – Get Free Report)’s stock price fell 6.6% during mid-day trading on Tuesday . The stock traded as low as $0.3750 and last traded at $0.3886. Approximately 316,716 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 3,902,358 shares. The stock had previously closed at $0.4160.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Scienture in a research report on Wednesday, June 24th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $1.50.

Check Out Our Latest Stock Report on SCNX

Scienture Trading Down 6.6%

The company has a market capitalization of $15.79 million, a price-to-earnings ratio of -0.15 and a beta of 3.28. The stock has a 50-day simple moving average of $0.38 and a 200-day simple moving average of $0.41.

Scienture (NASDAQ:SCNX – Get Free Report) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.15. The company had revenue of $0.06 million for the quarter, compared to analyst estimates of $0.40 million.

Institutional Inflows and Outflows

A hedge fund recently raised its position in Scienture stock. Geode Capital Management LLC raised its stake in Scienture Holdings, Inc. (NASDAQ:SCNX – Free Report) by 264.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 316,201 shares of the company’s stock after purchasing an additional 229,398 shares during the period. Geode Capital Management LLC owned 0.78% of Scienture worth $161,000 as of its most recent SEC filing. Institutional investors and hedge funds own 5.68% of the company’s stock.

Scienture Company Profile

(Get Free Report)

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.